In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum
about
Histoplasmosis: a clinical and laboratory updateSuccessful treatment of osseous blastomycosis without pulmonary or disseminated disease and review of the literature.In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungiPopulation pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies.The role of voriconazole in the treatment of central nervous system blastomycosis.Clinical and laboratory update on blastomycosis.Fusarium peritonitis successfully managed with posaconazole and catheter removal.In vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatumMelanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin.Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study.Antifungal use in HIV infection.Review of the safety and efficacy of voriconazole.Management of histoplasmosis.Antifungal pharmacotherapy for invasive mould infections.Voriconazole: a new triazole antifungal agent.Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.Systemic antifungal therapy: new options, new challenges.New and emerging antifungal agents: impact on respiratory infections.Quantitative Microplate-Based Growth Assay for Determination of Antifungal Susceptibility of Histoplasma capsulatum Yeasts.Voriconazole: review of a broad spectrum triazole antifungal agent.Management of intracranial fungal infections in patients with haematological malignancies.Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.Histoplasmosis: a review for clinicians from non-endemic areas.David and Goliath: chemical perturbation of eukaryotes by bacteria.Voriconazole use for endemic fungal infections.New and investigational triazole agents for the treatment of invasive fungal infections.New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.Pharmacology and clinical use of voriconazole.Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.Update on the optimal use of voriconazole for invasive fungal infections.Dimorphic fungal osteoarticular infections.Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum.Antifungal therapeutics for dimorphic fungal pathogens.Arthroconidia in Lung Tissue: An Unusual Histopathological Finding in Pulmonary Coccidioidomycosis.Large-Scale Evaluation of In Vitro Amphotericin B, Triazole, and Echinocandin Activity against Coccidioides Species from U.S. Institutions.In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.In vitro antifungal susceptibility profile and correlation of mycelial and yeast forms of molecularly characterized Histoplasma capsulatum strains from India.Endemic fungal infections in solid organ transplantation.Successful use of voriconazole for treatment of Coccidioides meningitis.Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole.
P2860
Q24675642-EFCAC2EE-DDB2-4504-B4E7-DBA589EB043BQ26998962-BFFB304D-8180-4FAE-87AC-3A0E4ABD0303Q28355507-23E89C1C-2290-4015-9B78-0A547356BFFDQ33392206-DC9A88DD-BF94-4697-B377-64B8DDBD95CFQ33499168-2557E3F4-12E4-4AFF-B672-3EDF5926963AQ33825592-E3A008CB-C99A-44AF-964E-38A369FFA204Q33967892-ED2B3E60-D0CF-4376-895C-BEF89F47E504Q34108468-78502E8A-AFEC-4934-B5C6-4FBF26E96B6DQ34142491-FD3BC77B-87D4-4CB7-A089-1EA7EAC89C3FQ34195380-B78DC33A-0A24-4839-B999-EC2F6442459CQ34519212-D7F3CCF7-E39D-4E4B-A33A-F0D3D52769E9Q34544679-A9FE565E-38D9-45A1-BBB5-0D73945AD04FQ34768480-2CF2AF65-8DFA-4AE0-A843-C9BF1916F181Q35058091-9EFFBF3D-E129-4A74-ADAE-555427A35058Q35069136-F45A56FF-DD7F-4903-9FFF-0BF4721280C4Q35072285-68799C1A-F641-408C-A243-9DEF05E2FB2EQ35585219-DED4844F-3A22-45CB-B34A-39A9A18F35F8Q35627629-DBE6C1D9-60F2-4DFB-BB05-BEF34D6857A2Q36066802-B493FB5D-8D1A-410D-9EC9-B6753BD902F0Q36164008-1B83B5FE-CA36-4312-8CBE-5D28FE88C984Q36286439-74CA6193-4C24-443F-8294-8791685DDEF4Q36491819-6BBE5233-F032-428C-91A9-C46A539187FEQ36511359-B07B4764-19B1-423E-A3F6-4875B189EAFBQ36577080-DBAF9B6C-6BDB-4C15-88F6-B4F2A92968C4Q37144791-0A6720AB-B7E7-4B6B-B28D-0968C72A028FQ37364295-187EF981-5793-4B32-8B93-F408111CA841Q37608276-EA819997-B18E-4A71-9273-7DE2ECCE86D0Q37641375-C6CDC36B-4534-423A-9F99-23CC38A7AE9AQ37810091-D1F2BCB0-6F5E-42C9-B1FC-59EC6A7EFB13Q37892901-223FCD21-BB78-42C6-B33D-C27629FC4DD6Q38221100-93D55F9F-3ED9-49B7-8859-0A362B90239AQ38283296-0BED1F11-AB18-4011-B354-45E8BB7A65D3Q38959083-696F07EB-61F1-404B-9E8C-3234C55E921BQ40106102-6A3C1BE8-E2C1-45C9-8454-C0A5BCC2D49CQ40368633-B55E1975-0F93-40CF-9A57-B1FC428A858CQ40968174-059A170C-52E4-4B21-93DB-7C7E9072F843Q42109717-E376701A-7601-42C7-B2DF-38098ED1ED09Q42272285-AA016678-9811-4563-90CD-6C5FF2BB3A8FQ43240160-D1780BB4-7759-4CE7-853F-CA6BB79A2990Q45097025-9095E391-2B91-404D-8125-4074331D5B82
P2860
In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
In vitro activities of voricon ...... is, and Histoplasma capsulatum
@ast
In vitro activities of voricon ...... is, and Histoplasma capsulatum
@en
type
label
In vitro activities of voricon ...... is, and Histoplasma capsulatum
@ast
In vitro activities of voricon ...... is, and Histoplasma capsulatum
@en
prefLabel
In vitro activities of voricon ...... is, and Histoplasma capsulatum
@ast
In vitro activities of voricon ...... is, and Histoplasma capsulatum
@en
P2093
P2860
P1476
In vitro activities of voricon ...... is, and Histoplasma capsulatum
@en
P2093
P2860
P304
P356
10.1128/AAC.44.6.1734-1736.2000
P407
P577
2000-06-01T00:00:00Z